[ Price : $8.95]
FDA says it needs cardiovascular outcome safety information on Takedas proposed fixed dose combination of alogliptin and Actos.[ Price : $8.95]
FDA approves a new indication for Spectrums Zevalin to treat some categories of patients with previously untreated follicular non-...[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on the evaluation of potential data sources for the Sent...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Novartis Banzel for the purpose of patent extension.[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Ortho McNeils Doribax for the purpose of patent extension...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Medtronics Talent Abdominal Stent Graft System.[ Price : $8.95]
Federal Register Notice: FDA releases its annual report on the status of postmarketing requirements and commitments for approved d...[ Price : $8.95]
An Institute of Medicine drug safety meeting discusses a potential drug approval lag reemerging at FDA due to drug safety concerns...